Acute Human Bocavirus 1 Infection in Children Hospitalized for Acute Bronchiolitis: A 2-Year Prospective Study

Tina Uršič1, Lara Lusa2,3, Franc Strle4

  • 1From the Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Insights

Human bocavirus 1 (HBoV1) replication was assessed in children hospitalized for acute bronchiolitis (AB). Active HBoV1 infections in AB patients showed high viral DNA and mRNA in nasopharyngeal samples, with plasma DNA detection.

Area of Science:

  • Pediatrics
  • Virology
  • Infectious Diseases

Background:

  • Human bocavirus 1 (HBoV1) is a known respiratory pathogen.
  • Acute bronchiolitis (AB) is a common respiratory illness in infants and young children.
  • The role of HBoV1 replication in the severity of AB requires further investigation.

Purpose of the Study:

  • To determine the proportion of HBoV1 replication in children hospitalized with AB.
  • To evaluate the clinical significance of HBoV1 replication in these patients.
  • To differentiate active HBoV1 infections from inactive ones.

Main Methods:

  • Prospective study design.
  • Detection of HBoV1 DNA and mRNA in nasopharyngeal (NP) samples from children with AB and healthy controls.
  • Analysis of HBoV1 DNA in plasma samples.

Main Results:

  • HBoV1 DNA was found in 12.1% of AB patients and 6% of controls.
  • A high rate of co-detection with other respiratory viruses was observed in AB patients (75.7%).
  • Active HBoV1 infection (DNA and mRNA positive) was confirmed in 24.3% of HBoV1 DNA-positive NP swabs, with concurrent detection of HBoV1 DNA in plasma.

Conclusions:

  • Children with acute HBoV1 infection and AB exhibit high viral DNA loads in NP samples.
  • Detection of HBoV1 mRNA and plasma DNA indicates active viral replication.
  • These findings suggest HBoV1 replication plays a role in the clinical course of acute bronchiolitis.
Abstract

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.4K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
174
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
211
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123